Fundz

Bit.Bio Raises In Excess Of $100 Million In First Close Of Series B Financing

PRIVATENov 05, 2021

Round Type

Series B

CambridgeshireInformation TechnologyFinancial ServicesSoftwareScience And EngineeringPayments

Description

Human cell coding company bit.bio today announces the first close of their Series B financing of $103 million.

Quick answer

bit.bio raised an undisclosed amount in a Series B round, dated November 5, 2021. bit.bio is based in Cambridgeshire, England, United Kingdom.

How much did bit.bio raise?
bit.bio raised an undisclosed amount in a Series B round on November 5, 2021.
What does bit.bio do?
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures.
Where is bit.bio based and how big is it?
bit.bio is based in Cambridgeshire, England, United Kingdom. Fundz records about 162 employees.
Who are the decision-makers at bit.bio?
Fundz holds 1 contact at bit.bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Financial Services and Science And Engineering around the same time

Companies in the same sectors as bit.bio that raised within 45 days of this round, from Fundz verified event records.

  • Anchorage Digital raised $350M (Funding Round) on December 15, 2021.
  • Anchorage Digital raised $350M (Series D) on December 15, 2021.
  • Vendia raised $21M on December 20, 2021.
  • Haystacks.Ai raised $5M (Seed) on December 16, 2021.
  • Galoy raised $3M (Seed) on December 15, 2021.
  • Mesh Payments raised $50M (Funding Round) on December 14, 2021.

Who to call at bit.bio, and when

A new round usually means bit.bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day bit.bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at bit.bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at bit.bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

bit.bio

Location

Cambridgeshire, England, United Kingdom

About

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment bit.bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for bit.bio's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

bit.bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.